Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Wald and Morris1 seem to have examined carefully
our article on the nutritional benefits of neonatal screening in cystic
fibrosis2 but they misunderstood some points and failed to
grasp the potential advantages of preventing malnutrition in patients
with cystic fibrosis.
They comment that our "study design is an ingenious one, but the analysis of the results is problematic." Ironically, the most ingenious feature is the very element they criticise with their comment that "a difficulty that is not discussed ... is that the data in children under 4 years are subject to selection bias." Selection bias was one of the challenges we overcame in our study design. Our randomisation protocol was designed to include a group that had been screened at birth and a standard diagnosis (control) group.
Once the controls were identified by the unblinding process at 4 years
of age, their anthropometric indices of nutritional status since birth
were